Access to medicines and treatment: latest news

Access to medicines and treatment resources

Access to medicines and treatment features

Access to medicines and treatment news from aidsmap

More news

Access to medicines and treatment news selected from other sources

  • Meet the Man Helping Patients Bring Cheap HIV-Preventing Drugs to Canada

    The Calgary nurse got the idea from 'Dallas Buyers Club.'

    13 hours ago | Vice
  • PrEP-ing for HIV prevention in Ireland

    Lack of access to HIV pre-exposure prophylaxis (PrEP) is presenting dilemmas for the HSE, clinicians, the medicines regulator and those seeking the medication in Ireland. A recent memo to healthcare professionals sent on behalf of the HSE’s Working Group on HIV pre-exposure prophylaxis (PrEP), discouraging them from directing patients to the activist-led website for information on sourcing pre-emptive antiretroviral therapy online, is a talking point among campaigners advocating for access.

    18 September 2017 | The Medical Independent
  • A Venezuelan woman had grown used to shortages. Then her HIV drugs ran out.

    Doctors are struggling to cope with a surging HIV/AIDS crisis that experts fear could become the worst in Latin America in years. Caracas’s largest hospitals are now scrambling to cope with an influx of both newly infected and deteriorating HIV patients, their emaciated bodies evoking the distressing images that defined the virus in the 1980s.

    11 September 2017 | Washington Post
  • Generic PrEP in France and Scotland challenges access across the UK

    The issue of drug procurement and pricing is complex but it is difficult to see how different patents should apply within Europe, and especially not within the UK.

    08 September 2017 | HIV i-Base
  • Gilead's Newer Tenofovir Patents

    The company may have found a way to protect its newest HIV franchise for longer than anticipated, perhaps 10 years longer than it suggests in its 10-K (see p. 15), in both the US and EU.

    15 August 2017 | Seeking Alpha
  • A massive second global wave of AIDS is coming — perhaps within the next 10 years

    Three problems are driving the global fight against HIV into a new danger zone. First, new infections increasingly involve forms of the virus that are already resistant to the primary drugs used to treat and prevent HIV infection. Second, the world is fast approaching the limits of manufacturing capacity for anti-HIV first-line drugs, and the ceiling is far lower for second- and third-line treatments. And third, there aren’t sufficient financial resources applied to the AIDS problem now, and signals from major donors — especially the U.S. government — offer a grim future of diminished resources and greater demands on very poor countries to finance their own HIV fights without outside help.

    31 July 2017 | Business Insider
  • WHO prequalifies first generic hepatitis C medicine and first HIV self-test

    WHO today prequalified the first generic version of sofosbuvir, a critical medicine for the treatment of hepatitis C. The development could expand access to treatment by increasing the number of quality-assured generic medicines on the market. Sofosbuvir, 400 mg tablet, is manufactured by Mylan Laboratories Ltd., India.

    22 July 2017 | World Health Organization
  • More people living with HIV in Kyiv accessing antiretroviral therapy

    A public–private partnership between the Elena Pinchuk ANTIAIDS Foundation and the city of Kyiv.

    14 July 2017 | UNAIDS
  • An arbitrary benchmark for access to new drugs

    Policy is an admission the UK cannot afford to be at the cutting edge.

    11 July 2017 | Financial Times
  • Senior MPs urge post-Brexit EU drug regulation deal

    The move would be "in the interests of public health and safety," say Greg Clark and Jeremy Hunt.

    04 July 2017 | BBC Health
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.